DGAT2 dysregulation has been linked to several diseases, including hepatocellular carcinoma (HCC) (18), severe sepsis (19), and MASLD (20), because of its role in regulating lipid homeostasis and cell cycle progression. This evidence concerns the gene DGAT2 and hepatocellular carcinoma.